PTX restrained HCC tumorigenesis partly via regulating the circ_0005785/miR-640/GSK3beta axis, hinting at a promising therapeutic target for the HCC treatment.
Paclitaxel inhibits hepatocellular carcinoma tumorigenesis by regulating the circ_0005785/miR-640/GSK3beta.